 Craig Forester
Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 1 | 2021 | 356 | 0.620 |
Why?
| | Protein Biosynthesis | 5 | 2021 | 389 | 0.610 |
Why?
| | Anemia, Aplastic | 1 | 2015 | 29 | 0.490 |
Why?
| | Cell Differentiation | 2 | 2021 | 1707 | 0.490 |
Why?
| | Proteome | 1 | 2018 | 345 | 0.470 |
Why?
| | Bone Marrow | 1 | 2015 | 248 | 0.450 |
Why?
| | Myelodysplastic Syndromes | 1 | 2015 | 118 | 0.450 |
Why?
| | Proteomics | 1 | 2018 | 855 | 0.400 |
Why?
| | Cysts | 1 | 2012 | 94 | 0.380 |
Why?
| | cdc25 Phosphatases | 2 | 2007 | 12 | 0.380 |
Why?
| | Immunosuppressive Agents | 1 | 2015 | 666 | 0.370 |
Why?
| | Skin Diseases | 1 | 2012 | 124 | 0.360 |
Why?
| | Mitosis | 2 | 2007 | 164 | 0.350 |
Why?
| | Cerebral Angiography | 1 | 2009 | 111 | 0.330 |
Why?
| | Protein Phosphatase 2 | 2 | 2007 | 30 | 0.320 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 66 | 0.320 |
Why?
| | CDC2 Protein Kinase | 1 | 2007 | 25 | 0.300 |
Why?
| | Brain Neoplasms | 2 | 2015 | 979 | 0.270 |
Why?
| | Signal Transduction | 2 | 2018 | 4526 | 0.260 |
Why?
| | Lung Diseases | 1 | 2012 | 710 | 0.250 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2018 | 361 | 0.250 |
Why?
| | Liver Neoplasms | 2 | 2019 | 521 | 0.250 |
Why?
| | Haploinsufficiency | 1 | 2021 | 43 | 0.190 |
Why?
| | Ribosomal Proteins | 1 | 2021 | 70 | 0.190 |
Why?
| | Extremities | 1 | 2021 | 113 | 0.180 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3087 | 0.170 |
Why?
| | Pseudouridine | 1 | 2019 | 4 | 0.170 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2409 | 0.170 |
Why?
| | Anemia, Macrocytic | 1 | 2019 | 4 | 0.170 |
Why?
| | Eye Abnormalities | 1 | 2019 | 10 | 0.170 |
Why?
| | RNA, Ribosomal, 18S | 1 | 2019 | 22 | 0.170 |
Why?
| | RNA, Small Nuclear | 1 | 2019 | 31 | 0.170 |
Why?
| | Genes, Tumor Suppressor | 1 | 2019 | 78 | 0.170 |
Why?
| | Diagnosis, Differential | 2 | 2015 | 1359 | 0.170 |
Why?
| | Endopeptidases | 1 | 2019 | 72 | 0.170 |
Why?
| | Craniofacial Abnormalities | 1 | 2019 | 59 | 0.160 |
Why?
| | Kell Blood-Group System | 1 | 2018 | 1 | 0.160 |
Why?
| | alpha-Thalassemia | 1 | 2018 | 4 | 0.160 |
Why?
| | Protein Processing, Post-Translational | 1 | 2021 | 400 | 0.160 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2019 | 81 | 0.160 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2018 | 10 | 0.160 |
Why?
| | ras Proteins | 1 | 2019 | 137 | 0.160 |
Why?
| | beta-Thalassemia | 1 | 2018 | 23 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 376 | 0.160 |
Why?
| | Puromycin | 1 | 2018 | 11 | 0.160 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2018 | 23 | 0.160 |
Why?
| | Isoantibodies | 1 | 2018 | 52 | 0.150 |
Why?
| | Ganglia, Spinal | 1 | 2018 | 42 | 0.150 |
Why?
| | K562 Cells | 1 | 2018 | 72 | 0.150 |
Why?
| | Carcinogenesis | 1 | 2019 | 177 | 0.150 |
Why?
| | Sciatic Nerve | 1 | 2018 | 56 | 0.150 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 224 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2021 | 448 | 0.150 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 555 | 0.150 |
Why?
| | Drug Discovery | 1 | 2018 | 124 | 0.140 |
Why?
| | Erythrocyte Transfusion | 1 | 2018 | 187 | 0.140 |
Why?
| | Axons | 1 | 2018 | 180 | 0.140 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 346 | 0.140 |
Why?
| | Survival Analysis | 2 | 2019 | 1221 | 0.130 |
Why?
| | Thioridazine | 1 | 2015 | 1 | 0.130 |
Why?
| | Ether-A-Go-Go Potassium Channels | 1 | 2015 | 4 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 416 | 0.130 |
Why?
| | RNA | 1 | 2021 | 821 | 0.120 |
Why?
| | Immunotherapy | 1 | 2019 | 480 | 0.120 |
Why?
| | Clonal Evolution | 1 | 2015 | 26 | 0.120 |
Why?
| | Medical Records | 1 | 2015 | 157 | 0.120 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 301 | 0.100 |
Why?
| | Evolution, Molecular | 1 | 2015 | 437 | 0.100 |
Why?
| | Radiography, Thoracic | 1 | 2012 | 165 | 0.090 |
Why?
| | Prostatic Neoplasms | 1 | 2018 | 927 | 0.090 |
Why?
| | Up-Regulation | 2 | 2019 | 824 | 0.090 |
Why?
| | Humans | 13 | 2021 | 115908 | 0.090 |
Why?
| | Mice | 6 | 2021 | 15075 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1817 | 0.090 |
Why?
| | Ribosomes | 2 | 2021 | 148 | 0.080 |
Why?
| | Intracranial Hemorrhages | 1 | 2009 | 76 | 0.080 |
Why?
| | Osteosarcoma | 1 | 2009 | 66 | 0.080 |
Why?
| | Mutation | 1 | 2019 | 3371 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2007 | 791 | 0.080 |
Why?
| | Cerebellar Neoplasms | 1 | 2009 | 131 | 0.080 |
Why?
| | Cerebellum | 1 | 2009 | 200 | 0.080 |
Why?
| | Animals | 8 | 2021 | 32123 | 0.080 |
Why?
| | Bone Neoplasms | 1 | 2009 | 194 | 0.070 |
Why?
| | Neoplasms | 1 | 2021 | 2112 | 0.070 |
Why?
| | 14-3-3 Proteins | 1 | 2006 | 13 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 4670 | 0.070 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 63 | 0.070 |
Why?
| | Xenopus Proteins | 1 | 2006 | 56 | 0.070 |
Why?
| | Xenopus | 1 | 2006 | 99 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 274 | 0.070 |
Why?
| | Infant, Newborn | 2 | 2019 | 5089 | 0.070 |
Why?
| | Male | 7 | 2019 | 56128 | 0.070 |
Why?
| | Female | 6 | 2019 | 60086 | 0.060 |
Why?
| | Phenotype | 2 | 2021 | 2861 | 0.050 |
Why?
| | Protein Binding | 1 | 2007 | 1919 | 0.050 |
Why?
| | Cell Line | 1 | 2007 | 2655 | 0.050 |
Why?
| | RNA Editing | 1 | 2021 | 20 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2015 | 9166 | 0.050 |
Why?
| | Body Patterning | 1 | 2021 | 126 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2019 | 27 | 0.040 |
Why?
| | 5' Untranslated Regions | 1 | 2019 | 51 | 0.040 |
Why?
| | Immune Evasion | 1 | 2019 | 47 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2019 | 114 | 0.040 |
Why?
| | Rats, Inbred BB | 1 | 2018 | 5 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2015 | 12616 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 510 | 0.040 |
Why?
| | Unfolded Protein Response | 1 | 2018 | 45 | 0.040 |
Why?
| | Cell Size | 1 | 2018 | 81 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2019 | 115 | 0.040 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 228 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2019 | 296 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2018 | 137 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2019 | 351 | 0.040 |
Why?
| | B7-H1 Antigen | 1 | 2019 | 138 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2018 | 399 | 0.040 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 526 | 0.030 |
Why?
| | Alleles | 1 | 2019 | 818 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 819 | 0.030 |
Why?
| | Down-Regulation | 1 | 2019 | 605 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 796 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 424 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2018 | 302 | 0.030 |
Why?
| | Child | 1 | 2015 | 18555 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 376 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 496 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 425 | 0.030 |
Why?
| | COS Cells | 1 | 2015 | 176 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2606 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2120 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2018 | 365 | 0.030 |
Why?
| | Adolescent | 2 | 2009 | 17955 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1392 | 0.030 |
Why?
| | Drosophila | 1 | 2015 | 132 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1842 | 0.030 |
Why?
| | Mice, Nude | 1 | 2015 | 639 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2015 | 850 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 1143 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 703 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1318 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 2262 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1165 | 0.030 |
Why?
| | Young Adult | 2 | 2019 | 10518 | 0.030 |
Why?
| | Models, Biological | 1 | 2019 | 1647 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2424 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2209 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2581 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 1970 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3582 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5035 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 4769 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3474 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2009 | 286 | 0.020 |
Why?
| | Femur | 1 | 2009 | 194 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6438 | 0.020 |
Why?
| | Adult | 2 | 2019 | 30820 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 1891 | 0.020 |
Why?
| | Phosphothreonine | 1 | 2006 | 6 | 0.020 |
Why?
| | Interphase | 1 | 2006 | 32 | 0.020 |
Why?
| | Holoenzymes | 1 | 2006 | 21 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 28 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2006 | 69 | 0.020 |
Why?
| | Intermediate Filaments | 1 | 2006 | 46 | 0.020 |
Why?
| | Infant | 1 | 2019 | 8002 | 0.020 |
Why?
| | Keratins | 1 | 2006 | 176 | 0.020 |
Why?
| | Protein Subunits | 1 | 2006 | 205 | 0.020 |
Why?
| | DNA Replication | 1 | 2006 | 204 | 0.020 |
Why?
| | HeLa Cells | 1 | 2006 | 568 | 0.020 |
Why?
| | Protein Kinases | 1 | 2006 | 306 | 0.020 |
Why?
| | Phosphorylation | 1 | 2006 | 1561 | 0.010 |
Why?
| | United States | 1 | 2018 | 12338 | 0.010 |
Why?
| | Aged | 1 | 2019 | 19299 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 27084 | 0.010 |
Why?
|
|
Forester's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|